Medical Licensing (MD/DO) · Independent exam preparation
Geriatric Medicine One-Day Exam Study Guide
Practise geriatric diagnosis, safer prescribing, functional assessment, and care decisions with 60 focused concepts, 20 clinical questions, and 20 recall cards.
By CertMedbry · Updated 19 October 2026
Practise distinguishing delirium from dementia, preventing treatment harm, interpreting functional decline, and matching care to an older adult’s goals. This guide selects 60 substantive concepts across the six official domains and pairs them with original questions and recall cards. The complete ABIM Geriatric Medicine Certification Examination blueprint defines the full examination scope; this selective guide does not cover every listed condition. Study planning should follow the official domain and subsection weights, including the combined 12.5% devoted to cognitive impairment and dementia.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which credential and examination pathway does this guide address?
The selected pathway is initial ABFM certification leading to the physician Certificate of Added Qualification in Geriatric Medicine. ABFM requires maintained family medicine certification, qualifying geriatric fellowship training, application approval, and successful examination completion. The official assessment name is Geriatric Medicine One-Day Exam. ABFM and ABIM jointly develop the examination; application requirements differ, while examination content and scoring are identical.
ABFM: Geriatric Medicine · 2026 Geriatric Medicine Certificate of Added Qualification One-Day Examination Information Booklet
How many questions are there, and how many are scored?
The examination contains up to 240 single-best-answer questions. Page 2 of the CERT blueprint states that approximately 40 are new questions that do not count toward the examinee’s score. These figures do not establish an exact guaranteed scored-question count. The 2026 booklet describes four modules, each containing a maximum of 60 questions.
Geriatric Medicine Blueprint: Certification Examination (CERT) · 2026 Geriatric Medicine Certificate of Added Qualification One-Day Examination Information Booklet
How long is the examination day?
Each of the four sessions allows up to two hours, giving up to eight hours of question time. The scheduled day is approximately ten hours, including instructions, an optional tutorial, optional survey, and 100 pooled minutes for scheduled breaks. Unscheduled breaks during a session consume that session’s time. Allow sufficient time for re-entry checks; the booklet advises allowing as much as ten minutes. Breaks taken after the pooled allowance is exhausted reduce remaining examination time.
2026 Geriatric Medicine Certificate of Added Qualification One-Day Examination Information Booklet
How is the examination delivered, and what item styles appear?
ABIM administers the computer-based examination through Pearson VUE test centers after ABFM approves eligibility. Questions use a single-best-answer multiple-choice format and may require interpretation of ECGs, imaging, laboratory data, graphs, or photomicrographs. The booklet describes timed modules and multiple examination forms; it does not describe computer-adaptive delivery. The official tutorial provides software familiarization. These 20 practice questions are independent learning drills.
ABFM: Geriatric Medicine One-Day Exam · 2026 Geriatric Medicine Certificate of Added Qualification One-Day Examination Information Booklet
Is initial certification open book, and how do continuing pathways differ?
Initial certification is closed book. The 2026 continuing certification one-day examination provides access to a restricted version of UpToDate. ABFM also offers a Longitudinal Knowledge Assessment for maintaining or regaining the CAQ under its applicable rules. Those continuing pathways should not be treated as interchangeable with this guide’s initial certification pathway.
2026 Geriatric Medicine Certificate of Added Qualification One-Day Examination Information Booklet · ABFM: Geriatric Medicine
Which blueprint and dates govern this guide?
The governing outline is the ABIM Geriatric Medicine Certification Examination blueprint, which prints August 2026. It gives no numbered version or explicit effective date. The ABFM 2026 booklet is v.1.0 and lists November 10, 2026 as the examination date. The April 2026 MOC blueprint is a separate document. Expanded geriatric blueprints are planned for publication in January 2028, with July 2028 LKA implementation and fall 2028 certification and traditional MOC implementation.
Geriatric Medicine Blueprint: Certification Examination (CERT) · 2026 Geriatric Medicine Certificate of Added Qualification One-Day Examination Information Booklet · Geriatric Medicine MOC Blueprint, April 2026 · ABIM: Expanded Blueprints
How is the official content weighted?
The CERT blueprint assigns Gerontology 5%; Diseases in the Elderly 45%; Geriatric Psychiatry 8.5%; Geriatric Syndromes 22.5%; Functional Assessment and Rehabilitation 3%; and Caring for Elderly Patients 16%. Cognitive impairment and dementia together account for 12.5%. Palliative care is a separately identified 5% subsection within Caring for Elderly Patients. Endocrinology and Nephrology together account for 7%. This selective guide allocates concepts 3/24/5/16/2/10 and questions and cards 1/9/2/4/1/3 across the six domains. Those counts do not reproduce all domain or subsection weights. The complete CERT outline defines the full scope.
Geriatric Medicine Blueprint: Certification Examination (CERT)
What passing standard and jurisdictional assumptions should candidates use?
The booklet describes an absolute passing standard; a numerical passing score is not established here. This is a United States physician board credential, although approved testing locations include other countries. Testing abroad does not create a different credential or replace ABFM eligibility requirements. The ethical principles taught here should be distinguished from jurisdiction-specific consent, surrogate, and reporting law.
2026 Geriatric Medicine Certificate of Added Qualification One-Day Examination Information Booklet · AMA Code of Medical Ethics: Informed Consent
What identification and test-center preparation does the 2026 booklet require?
Report to the assigned center 30 minutes before the appointment. Bring a current government-issued primary ID with a recent photograph and signature, with a name matching the Board’s record, plus a secondary ID bearing a signature. Both are required. Personal belongings must be stored outside the testing room, and security procedures include biometric identification and monitoring. Review the booklet’s prohibited-item and prior-approval requirements for medical supplies and comfort aids.
2026-Examination-Information-Booklet-Geriatric-Medicine-v.1.0.pdf
This is independent educational material for physicians developing subspecialty knowledge in geriatric medicine. It emphasizes diagnostic distinctions, treatment tradeoffs, function, and patient priorities.
Outline used: ABFM 2026 Geriatric Medicine Certificate of Added Qualification One-Day Examination Information Booklet, v.1.0; governing ABIM Geriatric Medicine Certification Examination (CERT) blueprint dated August 2026, consulted on 2026-10-10. The certification blueprint gives no numbered version or explicit effective date. The workbook label identifies the ABFM CAQ awarded through this shared examination; the assigned slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Gerontology5%
1.How do absolute and relative risk reductions change treatment interpretation?
Relative risk reduction describes the proportional decrease from baseline risk, whereas absolute risk reduction describes the actual difference in event probabilities. A reduction from 12% to 8% produces a 33% relative reduction but a four percentage point absolute reduction. The number needed to treat is the reciprocal of the absolute reduction expressed as a proportion. These measures require the same outcome and follow-up period to support a meaningful comparison.
Apply it
A trial follows similar older adults for three years. Stroke occurs in 9% receiving usual care and 6% receiving treatment. Calculate an absolute reduction of 3% and a number needed to treat of 34, rounding upward.
Common pitfall: A large relative reduction can conceal a small absolute benefit. Never calculate number needed to treat from the relative reduction or omit the follow-up period.
Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
2.How should confidence intervals guide interpretation of an uncertain benefit?
A confidence interval expresses uncertainty around an estimated effect under the analysis assumptions. For a risk ratio, one represents no difference; for a risk difference, zero does. An interval spanning benefit and harm may leave clinically important effects unresolved even when a significance threshold is not met. Interpretation should consider interval width, event frequency, study limitations, and whether the participants and outcomes resemble the patient facing the decision.
Apply it
A prevention trial reports a risk ratio of 0.85 with a 95% confidence interval of 0.60 to 1.20. Explain that the estimate favors treatment, but the results remain compatible with meaningful benefit and some harm.
Common pitfall: Failure to reach statistical significance does not establish equivalence. A wide interval may reflect inadequate precision rather than proof that treatment has no effect.
Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
3.How do age-related body composition and kidney changes alter exposure to drugs and alcohol?
Reduced muscle mass lowers creatinine generation, so a reassuring serum creatinine can coexist with impaired filtration. Reduced renal elimination can increase exposure to drugs or active metabolites. KDIGO recommends a kidney estimate suited to the medication decision and consideration of creatinine plus cystatin C when greater accuracy is needed. Reduced body water also helps explain why some older adults reach higher blood alcohol concentrations after the same intake. Increased sensitivity to sedation adds a pharmacodynamic hazard, as described by NIAAA.
Apply it
An older adult with muscle wasting develops adverse effects from a renally eliminated medication and stronger effects from a previously tolerated amount of alcohol. Reassess filtration, actual intake, and interacting sedatives rather than relying on a normal creatinine or past tolerance.
Common pitfall: A laboratory reference interval does not establish normal drug clearance. Previous tolerance also does not establish current safety after changes in body composition, kidney function, or medication exposure.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease · Aging and Alcohol | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Diseases in the Elderly45%
4.How should diabetes goals reflect health, function, and A1C reliability?
ADA goals distinguish relatively healthy older adults from those with complex health problems or very poor health. Reasonable A1C goals are generally below 7.0–7.5% for healthy adults and below 8.0% for many with complex health. With very complex health, severe cognitive impairment, or substantial functional dependence, avoid relying on A1C and prioritize avoiding hypoglycemia and symptomatic hyperglycemia. Altered red cell turnover, recent transfusion, blood loss, or erythropoietin treatment can also make A1C misleading; use verified glucose monitoring when it is unreliable.
Apply it
A patient with advanced dementia has recurrent low glucose episodes despite an apparently acceptable A1C. Use glucose patterns and caregiver observations to prevent hypoglycemia, dehydration, and distressing hyperglycemia. In a patient receiving erythropoietin, investigate discordance between A1C and measured glucose.
Common pitfall: Chronological age alone does not determine the target. An average A1C neither establishes safety nor reliably reflects glucose exposure when red cell turnover is abnormal.
5.When should diabetes treatment be deintensified or simplified?
Severe or recurrent hypoglycemia warrants reassessment of insulin, sulfonylureas, and other hypoglycemia-causing treatment even when A1C appears acceptable. Kidney impairment, inconsistent meals, and cognitive impairment amplify risk. Deintensification reduces or replaces treatment whose harms exceed benefits. Simplification reduces injections, glucose checks, calculations, and meal coordination to match the patient’s abilities and support. Merely lowering one dose may leave an unmanageable regimen intact.
Apply it
A patient repeatedly confuses mealtime insulin doses and has episodes requiring assistance after missed meals. Review glucose patterns, reduce hypoglycemia-causing exposure, and redesign the regimen around tasks the patient and caregivers can perform consistently.
Common pitfall: An acceptable A1C can conceal dangerous lows. Education or a small dose reduction may be insufficient when regimen complexity exceeds cognitive, visual, or manual capacity.
7.Which cardiorenal indications can justify treatment when A1C is already at goal?
For suitable older adults with type 2 diabetes and heart failure or CKD, SGLT2 inhibitors provide organ protection beyond glucose lowering. KDIGO also recommends them for adults with CKD and eGFR at least 20 mL/min/1.73 m² with urine albumin-to-creatinine ratio at least 200 mg/g, or heart failure irrespective of albuminuria, including appropriate patients without diabetes. GLP-1 receptor agonists with demonstrated cardiovascular benefit are an important option for established or high-risk ASCVD. Assess volume depletion with SGLT2 inhibitors and gastrointestinal intolerance or undernutrition with GLP-1 receptor agonists.
Apply it
An adult without diabetes has persistent albuminuric CKD, eGFR 38, and urine albumin-to-creatinine ratio 500 mg/g. Recognize an SGLT2 kidney-protection indication and assess suitability. Explain acute illness, prolonged fasting, and surgery interruption planning; an initial reversible eGFR decrease alone generally does not require stopping.
Common pitfall: A satisfactory A1C does not remove organ-protection indications. These drug classes have overlapping benefits, but their indications and tolerability constraints are not interchangeable.
ADA: Older Adults—Standards of Care in Diabetes, 2026 · KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
8.How do congestion relief and disease-modifying treatment differ in reduced-ejection-fraction heart failure?
For symptomatic HFrEF, the four foundational treatment classes are an ARNI, ACE inhibitor, or ARB; an evidence-based beta blocker; a mineralocorticoid receptor antagonist; and an SGLT2 inhibitor. Loop diuretics relieve fluid retention and congestion but do not replace these therapies. Select and titrate treatment using blood pressure, pulse, kidney function, potassium, volume status, and tolerability. SGLT2 benefit does not require diabetes. Sacubitril/valsartan must never overlap with an ACE inhibitor: wait at least 36 hours after the last ACE inhibitor dose before starting it. The heart-failure guideline also prohibits ARNI use in patients with any history of angioedema. These safety restrictions appear on slide 73 of the [AHA/ACC/HFSA heart-failure guideline slide set](https://professional.heart.org/-/media/832EA0F4E73948848612F228F7FA2D35.pdf).
Apply it
A stable 79-year-old with LVEF 30% takes a loop diuretic and lisinopril. Edema has resolved, but disease-modifying treatment remains incomplete. Assess suitability for the other foundational classes and replacement of lisinopril with sacubitril/valsartan. Before an ARNI transition, explicitly confirm that there is no history of angioedema and document the last lisinopril dose. If that dose was Monday at 08:00, sacubitril/valsartan cannot begin before Tuesday at 20:00, provided the patient otherwise remains suitable. Discontinue lisinopril and coordinate blood-pressure, kidney-function, potassium, and volume-status monitoring.
Common pitfall: Absence of edema does not establish optimized HFrEF treatment. A patient who tolerated an ACE inhibitor still requires the full 36-hour washout before sacubitril/valsartan; satisfactory blood pressure or laboratory results do not remove this requirement. A remote history of angioedema also excludes ARNI use under the heart-failure guideline. Worsening congestion requires active volume assessment rather than assuming that adding long-term therapies alone will promptly relieve symptoms.
Geriatric Medicine Blueprint: Certification Examination (CERT) · KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease · ADA: Older Adults—Standards of Care in Diabetes, 2026
9.How should bacteriuria be interpreted in an older adult with delirium?
Bacteriuria commonly occurs without urinary infection in older adults. IDSA recommends assessing other causes and observing an older patient with delirium and bacteriuria when local urinary symptoms and systemic infection signs are absent. A positive culture alone does not establish that urinary infection caused the mental status change. Fever, hemodynamic instability, or another sepsis presentation changes the assessment and may require urgent empiric treatment while the source is investigated.
Apply it
A nursing home resident develops inattention after poor intake and a medication change. Urine culture grows bacteria, but there is no dysuria, fever, or instability. Investigate dehydration and medication effects rather than treating the culture in isolation.
Common pitfall: Attributing delirium to any positive urine culture promotes unnecessary antibiotics. The recommendation to observe does not apply unchanged to a patient with systemic signs of severe infection.
IDSA 2019 Clinical Practice Guideline for Asymptomatic Bacteriuria
10.When does an upcoming urologic procedure justify treating asymptomatic bacteriuria?
IDSA recommends screening for and treating asymptomatic bacteriuria before endoscopic urologic procedures associated with mucosal trauma because bacteriuria increases postoperative sepsis risk. Obtain a urine culture and use targeted antimicrobial therapy rather than indiscriminate empiric treatment. The relevant distinction is anticipated mucosal injury in a contaminated urinary field. This exception does not mean that every urinary device, routine culture, or procedure without mucosal trauma requires treatment of asymptomatic bacteriuria.
Apply it
An asymptomatic older man has bacteriuria before transurethral surgery expected to breach urinary mucosa. Arrange culture-directed perioperative treatment because the planned procedure creates a specific infectious risk that is absent during ordinary observation at home.
Common pitfall: Applying the usual no-treatment rule without checking the procedure can miss an important exception. Applying the exception to all urinary testing leads back to overtreatment.
IDSA 2019 Clinical Practice Guideline for Asymptomatic Bacteriuria
11.Which findings distinguish symptomatic cystitis from asymptomatic bacteriuria?
New dysuria, urinary frequency, urgency, or suprapubic discomfort can localize symptoms to the lower urinary tract. Bacteriuria and pyuria support interpretation in context but do not independently distinguish symptomatic infection from asymptomatic colonization. Chronic urinary symptoms should be compared with baseline, and systemic signs require assessment for upper tract infection or another source. The diagnostic task is to connect an acute compatible syndrome with findings, rather than treating a laboratory abnormality alone.
Apply it
Two residents have positive cultures. One has unchanged chronic urgency; the other reports new painful urination and suprapubic discomfort. The second presentation supplies localizing symptoms that make symptomatic urinary infection substantially more likely than colonization.
Common pitfall: Pyuria, cloudy urine, and a positive culture can occur without symptomatic infection. Conversely, dismissing genuinely new localizing symptoms as normal aging can delay appropriate assessment.
IDSA 2019 Clinical Practice Guideline for Asymptomatic Bacteriuria
12.How are CKD chronicity, filtration, and albuminuria classified together?
KDIGO defines CKD as abnormalities of kidney structure or function present for at least three months with implications for health. Persistent eGFR below 60 mL/min/1.73 m² or markers such as albuminuria can establish the abnormality. Classify by cause, GFR, and albuminuria: G3a is eGFR 45–59 and G3b 30–44; A1 is urine albumin-to-creatinine ratio below 30, A2 30–300, and A3 above 300 mg/g. Lower filtration and greater albuminuria independently increase risk.
Apply it
Persistent eGFR 52 and urine albumin-to-creatinine ratio 420 mg/g over six months indicate G3a A3 CKD. A single eGFR of 48 during vomiting instead requires assessment for an acute process and evidence of chronicity.
Common pitfall: One low eGFR does not prove CKD, and waiting three months is inappropriate when acute kidney injury requires action. An eGFR above 60 also does not exclude CKD with persistent kidney-damage markers.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
13.How should hypertension treatment in an older adult with CKD balance cardiovascular benefit and tolerability?
For adults with high blood pressure and nondialysis CKD, KDIGO suggests a systolic target below 120 mm Hg when tolerated, using standardized office measurement. This target should not be applied directly to casually measured readings. Consider less intensive treatment with frailty, high fall risk, very limited life expectancy, or symptomatic postural hypotension. In albuminuric CKD, an ACE inhibitor or ARB may provide kidney protection; monitor kidney function and potassium and avoid combined ACE inhibitor–ARB treatment.
Apply it
An 82-year-old with CKD has a hurried clinic reading of 138/72 and dizziness on standing. Obtain standardized and postural measurements and review volume status and medicines before escalating treatment to chase a numerical target.
Common pitfall: The target depends on measurement technique and tolerance. Age alone does not justify undertreatment, while symptomatic hypotension should not be ignored merely because seated pressure exceeds a guideline target.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease · CDC STEADI: Measuring Orthostatic Blood Pressure
14.How should kidney function and potassium be monitored after renin–angiotensin blockade?
ACE inhibitors and ARBs can lower intraglomerular pressure and increase potassium, so KDIGO recommends checking blood pressure, creatinine, and potassium within two to four weeks after initiation or dose increase. A modest creatinine rise may reflect the expected hemodynamic effect. A rise greater than 30% within four weeks warrants evaluation. Hyperkalemia can often be managed rather than automatically stopping treatment; symptomatic hypotension or uncontrolled hyperkalemia may require reduction or discontinuation.
Apply it
After an ARB increase, an older adult’s creatinine rises substantially and standing symptoms develop. Review volume status, interacting medications, potassium, and the magnitude of the change before deciding whether to correct contributors or reduce treatment.
Common pitfall: Stopping an ACE inhibitor for every small creatinine increase can remove useful therapy. Ignoring a large increase, symptomatic hypotension, or uncontrolled potassium elevation is equally unsafe.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
15.How should secondary stroke prevention be connected to the cause of the event?
After stroke, prevention should address the identified mechanism alongside blood pressure, cholesterol, smoking, activity, and medication adherence. NHLBI describes antiplatelet treatment for appropriate patients and anticoagulation when atrial fibrillation creates an embolic indication. Selected carotid disease may require a procedural assessment. These interventions have different targets; they should not be treated as interchangeable clot-prevention options. New stroke signs still require an emergency response even while preventive treatment is being taken.
Apply it
A stroke survivor is found to have atrial fibrillation. Reassess embolic prevention using the AF anticoagulation guideline rather than assuming that an existing aspirin prescription resolves the indication. Review bleeding symptoms and adherence with the patient.
Common pitfall: A prior stroke does not determine one universal antithrombotic regimen. Prevention must account for stroke mechanism, valve conditions, contraindications, and the risks of unnecessary combined antithrombotic exposure.
Stroke - Recovery | NHLBI, NIH · 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
16.How is CHA2DS2-VASc calculated and translated into an anticoagulation decision?
CHA2DS2-VASc assigns one point each for heart failure, hypertension, diabetes, vascular disease, age 65–74, and female sex; age at least 75 and prior stroke, TIA, or systemic embolism each receive two points. Use only one age category. Anticoagulation is recommended at estimated annual thromboembolic risk at least 2%, exemplified by scores at least 2 in men or 3 in women. At 1% to less than 2%, exemplified by 1 in men or 2 in women, anticoagulation is reasonable. Female sex acts as a risk modifier; score-to-risk estimates vary across populations.
Apply it
A 78-year-old man has hypertension and clinical paroxysmal AF, with no heart failure, diabetes, vascular disease, or prior stroke, TIA, or embolism. His score is 2 for age plus 1 for hypertension, totaling 3: anticoagulation is recommended if suitable. A 68-year-old man with none of those conditions scores 1 from age alone, placing him in the category where anticoagulation is reasonable.
Common pitfall: Do not count age twice or assume intermittent AF removes stroke risk. Bleeding assessment should identify modifiable hazards rather than function as an automatic veto; shared decisions must also consider contraindications and patient priorities.
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
17.Which valve conditions change anticoagulant selection in atrial fibrillation?
DOACs are generally preferred over warfarin for eligible patients with AF, but mechanical heart valves and rheumatic mitral stenosis or mitral stenosis of moderate or greater severity require a different approach. The guideline recommends warfarin for AF with those mitral stenosis conditions and for mechanical valves. Other valve diseases, such as isolated aortic stenosis or mitral regurgitation, do not automatically impose the same exclusion. Identify the exact lesion rather than using an imprecise valve disease label.
Apply it
Two patients with AF need stroke prevention: one has a mechanical mitral valve, and the other has native aortic regurgitation. The mechanical prosthesis establishes a warfarin indication; the native regurgitant lesion alone does not exclude a DOAC.
Common pitfall: Both treating every valve disorder as a DOAC exclusion and overlooking moderate mitral stenosis are errors. The specific lesion and prosthesis type are decisive.
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
18.How should orthostatic blood pressure be measured and interpreted?
CDC STEADI recommends having the patient lie down for five minutes, measuring blood pressure and pulse, then repeating measurements after standing for one and three minutes. A systolic decrease of at least 20 mm Hg, a diastolic decrease of at least 10 mm Hg, or lightheadedness or dizziness is abnormal in this assessment. Interpret findings alongside symptoms, volume status, and medications. The CERT blueprint places orthostatic hypotension under Cardiovascular disease; it also contributes to falls assessment.
Apply it
After five minutes supine, blood pressure is 146/78; at one minute standing it is 120/70 with dizziness. Recognize an abnormal response, protect standing safety, and assess volume depletion and medication contributors.
Common pitfall: A normal seated pressure or a standing pressure within a usual range does not negate a substantial symptomatic postural decrease. Systolic and diastolic thresholds do not both have to be met.
CDC STEADI: Measuring Orthostatic Blood Pressure · Geriatric Medicine Blueprint: Certification Examination (CERT)
19.When does a fragility fracture justify treatment, and how should treatment feasibility be assessed?
BHOF recommends pharmacologic treatment after a hip or vertebral fracture regardless of bone mineral density in the populations addressed by its guide. Assess secondary contributors, falls, calcium and vitamin D adequacy, and medication suitability. Oral bisphosphonates require correct administration: inability to remain upright, important esophageal emptying disorders, or inability to follow instructions can make the route unsuitable. Kidney function and hypocalcemia also require assessment; renal restrictions vary by agent.
Apply it
A postmenopausal woman has a low-trauma hip fracture and T-score −1.8. Recognize a secondary prevention indication. If she also has an esophageal stricture and cannot reliably remain upright, assess an appropriate alternative rather than defaulting to an oral bisphosphonate.
Common pitfall: An osteopenic T-score does not erase a hip or vertebral fracture indication. Choosing a nonoral route does not eliminate the need to assess that treatment’s contraindications and follow-up requirements.
The clinician's guide to prevention and treatment of osteoporosis, 2022—mirrored primary publication
20.Which sudden neurologic changes require an emergency stroke response?
Sudden unilateral weakness or numbness, speech or comprehension difficulty, visual loss, or new loss of balance or coordination can signal stroke. Record when symptoms began and activate emergency medical services. Symptoms that resolve may represent a TIA and still require urgent assessment. The abrupt focal pattern is the discriminating cue; it should not be attributed to aging or an established dementia. NHLBI stroke guidance emphasizes immediate action for recurrent stroke signs.
Apply it
An older adult suddenly cannot name familiar objects and develops right arm weakness during breakfast. Call emergency services and report the observed onset. Do not wait for symptoms to persist or arrange a routine cognitive appointment.
Common pitfall: Resolution does not establish a harmless episode. Avoid assuming that all strokes produce the same combination of facial droop, weakness, and speech changes.
Geriatric Medicine Blueprint: Certification Examination (CERT) · Stroke - Recovery | NHLBI, NIH
21.How should post-bronchodilator spirometry establish and confirm airflow obstruction in suspected COPD?
In a compatible clinical presentation, GOLD uses a post-bronchodilator FEV1/FVC below 0.70 to establish the airflow-obstruction threshold. FEV1 is the forced volume exhaled in the first second; FVC is total forced vital capacity. When the post-bronchodilator ratio is between 0.60 and 0.80, repeat spirometry on a separate occasion should confirm the finding because biological variation can change classification. This confirmation requirement is specified in the [GOLD Science Committee report](https://publications.ersnet.org/lookup/doi/10.1183/13993003.01603-2024).
Apply it
A former smoker with progressive exertional dyspnea has post-bronchodilator FEV1 1.50 L and FVC 2.50 L, yielding 0.60. The current result meets the obstruction threshold, but repeat testing on a separate occasion is needed to confirm persistent obstruction. A ratio of 0.74 does not meet the threshold and also lies within the repeat-testing range.
Common pitfall: A single ratio of 0.60 should not be described as definitive confirmation. Smoking history, chest radiography, symptoms, and bronchodilator responsiveness alone also cannot establish COPD or reliably separate it from asthma.
23.Why must denosumab discontinuation be planned?
Denosumab’s antiresorptive effect reverses after treatment stops, with rapid bone loss and increased vertebral fracture risk, including multiple vertebral fractures. The BHOF guide therefore advises against an unplanned drug holiday and recommends subsequent antiresorptive treatment when denosumab is discontinued. Before starting, assess whether follow-up and a transition plan are feasible. This differs from selected bisphosphonate situations in which residual skeletal drug effects can support a carefully considered treatment holiday.
Apply it
A patient wishes to stop denosumab because transportation to appointments has become difficult. Arrange a clinically appropriate transition and solve access barriers rather than simply canceling future injections and waiting for the next routine density scan.
Common pitfall: Applying the idea of a bisphosphonate holiday to denosumab overlooks its different offset of action. Treatment interruption needs an active prevention plan, not passive observation.
The clinician's guide to prevention and treatment of osteoporosis, 2022—mirrored primary publication
24.Why are exercise and weight management central to knee osteoarthritis care?
The ACR/Arthritis Foundation guideline strongly recommends exercise for knee and hip osteoarthritis and weight loss for affected patients who are overweight or obese. Exercise can improve pain and function through strength, conditioning, and improved movement capacity despite persistent structural disease. The program should fit ability, preferences, and access; supervised approaches may help. Weight reduction reduces mechanical loading, and combining it with exercise provides a practical foundation rather than relying exclusively on analgesic escalation.
Apply it
An older adult with knee osteoarthritis avoids walking because movement seems harmful. Develop a tolerable strengthening and activity plan, consider supervision, and discuss gradual weight reduction when appropriate to improve function and confidence over time.
Common pitfall: Radiographic degeneration does not mean movement should stop. Prolonged inactivity can worsen weakness and disability even when it temporarily reduces activity-related discomfort in the joint.
2019 ACR/Arthritis Foundation Guideline for Osteoarthritis of the Hand, Hip, and Knee
25.When should a topical NSAID be considered for knee osteoarthritis?
Topical NSAIDs are strongly recommended for knee osteoarthritis, and the guideline favors considering local therapy before oral NSAIDs because systemic exposure is lower. This matters when kidney, cardiovascular, gastrointestinal, or medication interaction risks make systemic therapy problematic. Lower exposure does not mean zero risk. The recommendation cannot simply be transferred to hip osteoarthritis, where the depth of the joint makes a meaningful topical effect less plausible and evidence is insufficient.
Apply it
A patient with localized knee pain and increased systemic NSAID risk wants medication alongside exercise. Consider a topical NSAID after reviewing suitability, explain correct use, and monitor response rather than defaulting immediately to an oral agent.
Common pitfall: A topical product is not automatically harmless, and evidence for one joint cannot be assumed for another. Deep hip pain requires a different treatment assessment.
2019 ACR/Arthritis Foundation Guideline for Osteoarthritis of the Hand, Hip, and Knee
26.How should iron-deficiency anemia be diagnosed and investigated?
In anemia, AGA recommends a ferritin cutoff of 45 ng/mL rather than 15 to identify iron deficiency; inflammation or CKD may require transferrin saturation and inflammatory context. Men and postmenopausal women with unexplained iron-deficiency anemia generally need upper endoscopy and colonoscopy. If celiac disease is plausible, begin with serology and biopsy if positive. After unrevealing bidirectional endoscopy, consider noninvasive H pylori testing. In uncomplicated asymptomatic patients, an initial iron trial is favored over routine immediate capsule endoscopy; persistent anemia, alarm features, or management-changing small-bowel concerns require reassessment.
Apply it
A postmenopausal woman has hemoglobin 9.8 g/dL, MCV 74 fL, and ferritin 28 ng/mL. Confirm iron deficiency, review other explanations, and discuss bidirectional endoscopy and iron replacement. If evaluation is negative, choose subsequent testing using symptoms, treatment response, and relevant malabsorption or bleeding risks.
Common pitfall: Microcytosis alone does not prove iron deficiency, and elevated ferritin during inflammation does not exclude it. A negative endoscopic evaluation should not end reassessment of persistent or recurrent anemia.
Anemia - Diagnosis | NHLBI, NIH · PIIS0016508520348472-1.pdf
27.When does suspected giant cell arteritis require immediate treatment?
New headache, jaw claudication, scalp symptoms, and visual disturbance in an older adult should raise concern for giant cell arteritis. Threatened vision requires urgent treatment because ischemic injury can become irreversible. The ACR/Vasculitis Foundation guideline conditionally favors intravenous pulse glucocorticoids over high-dose oral treatment when vision loss is threatened. Diagnostic confirmation should proceed promptly, preferably obtaining temporal artery biopsy within two weeks of starting glucocorticoids, but biopsy arrangements must not postpone treatment. Negative biopsy does not automatically exclude segmental or extracranial disease.
Apply it
An older adult develops a new temporal headache, pain with chewing, and brief monocular dimming. Arrange urgent treatment and specialist assessment while pursuing biopsy. If biopsy is negative despite a convincing presentation, integrate the clinical findings and appropriate vascular imaging.
Common pitfall: Waiting for biopsy results before treating threatened vision can allow irreversible loss. Starting glucocorticoids does not immediately make biopsy worthless; the intravenous recommendation for threatened vision is conditional.
2021 ACR/Vasculitis Foundation Guideline for Giant Cell Arteritis and Takayasu Arteritis
29.Which hearing pattern suggests presbycusis?
Age-related hearing loss usually develops gradually and affects both ears. Difficulty understanding speech, particularly amid background noise, may be more prominent than an inability to hear any sound. Because progression is slow, patients may underestimate impairment or attribute communication problems to others. NIDCD recommends evaluation and appropriate hearing support. A sudden change, marked asymmetry, or associated acute neurologic symptoms should prompt consideration of another process rather than a reflex diagnosis of normal aging.
Apply it
An older adult increasingly misses conversation in restaurants and turns up the television over several years. Ask about the pattern, examine for treatable contributors, and arrange hearing assessment rather than attributing the communication difficulty to poor attention.
Common pitfall: Age makes presbycusis common but does not explain every hearing complaint. Labeling sudden or asymmetric loss as aging can delay assessment of a more urgent condition.
30.Why is sudden hearing loss an urgent presentation?
Sudden sensorineural hearing loss can develop at once or over a few days and often affects one ear. Patients may describe waking with reduced hearing, fullness, tinnitus, or dizziness and may incorrectly assume wax or congestion. NIDCD characterizes sudden deafness as a medical emergency requiring immediate assessment. Prompt examination and audiometry distinguish conductive obstruction from sensorineural loss, and early treatment offers a better opportunity for recovery than delayed reassurance or routine follow-up.
Apply it
An older adult awakens with unilateral hearing loss and tinnitus but no visible canal obstruction. Arrange urgent evaluation for sudden sensorineural hearing loss instead of scheduling an ordinary age-related hearing assessment several weeks later in clinic.
Common pitfall: Ear fullness does not prove wax or congestion. Waiting for spontaneous improvement can consume a time-sensitive opportunity to diagnose and treat sensorineural hearing loss.
Geriatric Psychiatry8.5%
31.Which features support a depressive episode in an older adult?
Depression involves persistent symptoms that interfere with daily functioning, typically present most of the day nearly every day for at least two weeks. Depressed mood or loss of interest is central, accompanied by changes such as sleep, appetite, energy, concentration, guilt, or thoughts of death. Older adults may emphasize physical or cognitive complaints rather than sadness. Establish duration, change from baseline, functional impact, and safety concerns instead of assuming withdrawal is an inevitable consequence of aging.
Apply it
A previously engaged older adult has three weeks of anhedonia, early waking, poor appetite, guilt, and reduced participation. Assess a depressive episode and suicide risk while reviewing medical contributors rather than labeling the change as ordinary aging.
Common pitfall: The absence of volunteered sadness does not exclude depression. A symptom checklist also needs context because medical illness and medication effects can produce overlapping complaints.
32.Which clues should prompt assessment of harmful alcohol use in later life?
Falls, unexplained bruising, worsening memory, poor appetite, sleep problems, and neglected self-care can accompany harmful alcohol use. Ask about actual intake and use of alcohol for sleep or distress. Alcohol combined with sedating medicines can amplify impaired attention and balance and increase overdose risk. The NIAAA aging guidance emphasizes that harms can emerge at previously tolerated amounts.
Apply it
An older adult with recurrent falls drinks at bedtime and takes a sleep medicine. Review both exposures together, assess alcohol-related impairment, and develop a treatment plan rather than treating the falls and insomnia as unrelated complaints.
Common pitfall: A long history of the same intake does not exclude new harm. Alcohol-related symptoms can resemble depression or cognitive disease and may coexist with either.
Aging and Alcohol | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
33.When do suicidal thoughts require immediate emergency assessment?
The NIMH adult outpatient safety assessment treats current suicidal thoughts as an indication for urgent mental health evaluation and directs clinicians not to leave the patient alone. Ask directly about current thoughts, plan, intent, access to means, and past attempts. Protective relationships do not cancel an acute risk finding. Maintain safety and arrange an appropriate emergency assessment; do not rely on a future appointment or a promise to seek help if the person feels worse.
Apply it
An older adult says he is thinking of killing himself now and has access to a firearm. Keep him under observation, address access to lethal means through an appropriate safety response, and arrange immediate emergency evaluation.
Common pitfall: A calm demeanor, supportive family, or willingness to promise safety does not establish low risk. Current suicidal thinking requires an active response rather than routine follow-up.
NIMH: Adult Outpatient Brief Suicide Safety Assessment Guide
34.How do mania and hypomania distinguish bipolar I and bipolar II, and why does this change depression treatment?
Bipolar I requires a manic episode; a depressive episode is not required. Mania involves a distinct elevated, expansive, or irritable mood with increased energy or activity, generally lasting at least seven days, or any duration when hospitalization is necessary, with marked impairment, hospitalization, or psychosis. Bipolar II requires hypomania and major depression without a manic episode. Hypomania lasts at least four consecutive days with an observable change but without marked impairment, hospitalization, or psychosis. Decreased need for sleep, increased goal-directed activity, pressured speech, and grandiosity help discriminate these episodes. Antidepressant monotherapy can precipitate mania or rapid cycling.
Apply it
An older adult presenting with depression describes a previous eight-day episode of little sleep without fatigue, unusually expansive plans, excessive activity, and hospitalization for disruptive behavior. Evaluate bipolar I even if no earlier depression occurred, and select a bipolar treatment plan rather than antidepressant monotherapy.
Common pitfall: Insomnia with fatigue or irritability alone does not establish mania. Obtain longitudinal and collateral history and assess medical, medication, and substance causes; new late-life mood elevation requires particular attention to these alternatives.
Bipolar Disorder - National Institute of Mental Health (NIMH)
35.How should depression treatment be matched to severity and urgency?
Evidence-based psychotherapies include cognitive behavioral therapy and interpersonal therapy. Psychotherapy is often an initial choice for milder depression; medication is commonly included initially for moderate or severe illness, with combined care suited to clinical needs and preferences. ECT is an option for severe depression, including earlier use when illness becomes life-threatening through inability to eat or drink or high suicide risk. Immediate suicide-safety assessment and protection remain separate requirements.
Apply it
An older adult with mild depression who prefers therapy may start accessible CBT or interpersonal therapy with follow-up. Severe depression causing refusal of food and fluids warrants urgent specialist assessment, medical stabilization, and consideration of ECT rather than waiting through prolonged sequential outpatient trials.
Common pitfall: Treatment selection must reflect severity, nutrition, safety, access, and preferences. Choosing ECT or an antidepressant does not itself resolve immediate suicide risk.
NIMH: Depression · NIMH: Adult Outpatient Brief Suicide Safety Assessment Guide
Geriatric Syndromes22.5%
6.How should cognitive and behavioral medicines be selected in dementia with Lewy bodies?
The DLB Consortium supports cholinesterase inhibitors such as rivastigmine or donepezil for cognition, global function, and activities of daily living; hallucinations and delusions may also improve. Establish target symptoms and monitor benefit, pulse, syncope, gastrointestinal effects, appetite, and weight. Memantine has less certain efficacy in DLB. Before treating behavioral symptoms, assess pain, acute illness, medication effects, and environmental triggers. Antipsychotics carry mortality risk in dementia and can cause severe sensitivity reactions in DLB, so avoid reflex prescribing.
Apply it
A patient with DLB has declining attention and distressing hallucinations after reversible contributors are addressed. Consider a cholinesterase inhibitor with explicit functional and symptom goals, review bradycardia and syncope history, and monitor tolerability and response.
Common pitfall: Dopamine blockade can worsen parkinsonism or provoke serious sensitivity. A quiet, recognized hallucination that does not distress the patient does not automatically require medication.
Geriatric Medicine Blueprint: Certification Examination (CERT) · Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, 2017 · NIH: Lewy Body Dementia—Information for Patients, Families, and Professionals, September 2013—mirrored booklet
22.What makes an initial cognitive assessment more informative than a screening score alone?
Establish the onset, tempo, affected cognitive domains, and change in daily independence using the patient’s account and collateral history. Test cognition with attention to hearing, vision, language, literacy, education, and cultural context. Review mood, sleep, medications, substances, neurologic findings, and systemic illness; use laboratory studies and structural imaging to investigate plausible contributors and alternative causes. Formal neuropsychological assessment helps when bedside testing and history leave uncertainty. Serial assessment can distinguish persistent progression from transient impairment.
Apply it
An older adult performs poorly on a verbally administered screen without working hearing aids. Restore communication and reassess before interpreting the score. Separately investigate the family’s report of progressive medication errors and getting lost rather than dismissing those observations if the repeat score improves.
Common pitfall: A low score neither identifies the cause nor establishes functional dependence. Sudden change requires delirium assessment; rapid progression over weeks or months warrants investigation beyond a routine slowly progressive dementia formulation.
Geriatric Medicine Blueprint: Certification Examination (CERT) · the-diagnosis-of-mild-cognitive-impairment-due-to-alzheimer%27s.pdf · Hartford Institute for Geriatric Nursing: Delirium Prevention and Management
28.How should a dementia care plan respond to demonstrated safety and support needs?
Translate cognitive findings into specific daily risks: medication errors, unsafe cooking, financial mistakes, getting lost, driving difficulty, falls, and inability to summon help. Assess observed performance and collateral examples, then match supervision, task assistance, environmental changes, and predictable routines to the impairment. Preserve participation in tasks the patient can still perform. Discuss caregiver capacity, future care preferences, and decision-making arrangements while the patient can participate, and revisit the plan as function changes.
Apply it
A patient with dementia still dresses independently but takes medicines twice and becomes lost on familiar walks. Arrange reliable medication administration and a safer supported walking plan, assess other navigation-dependent activities, and establish whom the caregiver can contact when needs escalate.
Common pitfall: A diagnosis alone does not specify the necessary supervision. Conversely, intact basic self-care does not establish safety for medication use, finances, navigation, or living alone.
Geriatric Medicine Blueprint: Certification Examination (CERT) · NIH: Lewy Body Dementia—Information for Patients, Families, and Professionals, September 2013—mirrored booklet · HIGN Try This: The Lawton Instrumental Activities of Daily Living Scale · AMA Code of Medical Ethics: Decisions for Adult Patients Who Lack Capacity
36.Which clinical features and chronology distinguish dementia with Lewy bodies?
Core DLB features include fluctuating cognition, recurrent well-formed visual hallucinations, REM sleep behavior disorder, and spontaneous parkinsonism. Probable DLB can be supported by at least two core features, or one core feature with an indicative biomarker. Dementia before, concurrently with, or within one year of parkinsonism favors DLB; dementia after longer-established Parkinson disease is termed Parkinson disease dementia. Nondistressing hallucinations may not need medication, and serious antipsychotic sensitivity makes reflex dopamine blockade hazardous.
Apply it
Progressive cognitive decline with detailed visual hallucinations, marked alertness fluctuations, and parkinsonism beginning within six months supports DLB. Review illness, medicines, vision, and environmental contributors before treating hallucinations, especially when they are recognized and comfortable.
Common pitfall: A single hallucination during acute illness is insufficient. Determine symptom onset from collateral history rather than assuming the dates of diagnostic labels establish chronology.
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, 2017 · NIH: Lewy Body Dementia—Information for Patients, Families, and Professionals, September 2013—mirrored booklet
37.What distinguishes mild cognitive impairment from dementia?
MCI involves cognitive decline beyond expected aging while independence is substantially preserved. Complex tasks may require more effort, time, or compensatory strategies. Dementia produces cognitive impairment that interferes with independent daily function. Establish objective cognitive findings, change from baseline, and actual task performance. MCI does not inevitably progress to dementia. The NIA–Alzheimer’s Association clinical criteria emphasize preserved independence and longitudinal assessment.
Apply it
A patient has demonstrable memory decline but continues to manage medication and finances accurately using reminders. Assess MCI and follow change over time. Dependence caused by cognitive errors in those tasks would shift the functional interpretation.
Common pitfall: A screening score alone does not establish dementia. Conversely, preserved dressing and eating do not prove preserved independence in complex activities.
Geriatric Medicine Blueprint: Certification Examination (CERT) · the-diagnosis-of-mild-cognitive-impairment-due-to-alzheimer%27s.pdf · HIGN: The Lawton Instrumental Activities of Daily Living Scale
38.Which pattern supports an Alzheimer-type dementia assessment?
A typical Alzheimer-type dementia has gradual progression over months to years, commonly beginning with impaired learning and retention of new information before broader cognitive and functional decline. Nonamnestic presentations also occur. The 2011 NIA–AA clinical framework requires a progressive dementia syndrome and assessment of competing explanations, including major cerebrovascular disease, DLB features, other neurologic illness, and medication effects. These clinical features are described in the [NIA–AA Alzheimer dementia recommendations](https://www.med.upenn.edu/digitalneuropathologylab/assets/user-content/documents/educational-resources/the-diagnosis-of-dementia-due-to-alzheimer%27s-disease.pdf).
Apply it
An older adult repeatedly forgets recent conversations and gradually loses independent bill management over two years. Assess a progressive dementia syndrome and its cause. An abrupt overnight worsening requires an additional evaluation for delirium.
Common pitfall: Memory complaints or a brief test alone do not establish Alzheimer disease. Early hallucinations, parkinsonism, abrupt focal deficits, or major vascular disease should broaden the differential and may indicate mixed pathology.
Geriatric Medicine Blueprint: Certification Examination (CERT) · the-diagnosis-of-mild-cognitive-impairment-due-to-alzheimer%27s.pdf
39.Which features identify delirium rather than stable dementia?
Delirium is characterized by an acute change with a fluctuating course and impaired attention, often accompanied by disorganized thinking or altered consciousness. Baseline dementia increases vulnerability but does not explain a sudden change by itself. Hypoactive delirium may present as quiet withdrawal and be easily missed. Establish baseline through collateral history and investigate precipitating illness, medications, pain, dehydration, retention, constipation, and environmental disruption. Recognition should lead to a search for causes and supportive care.
Apply it
A patient with mild dementia becomes unusually sleepy and cannot sustain attention the morning after surgery. Compare with baseline, assess for delirium and contributing causes, and avoid assuming that the chronic cognitive disorder suddenly progressed overnight.
Common pitfall: Agitation is not required for delirium. Quietness can conceal serious acute brain dysfunction, particularly when a patient already has dementia or communication difficulties at baseline.
Hartford Institute for Geriatric Nursing: Delirium Prevention and Management
40.How do multicomponent measures prevent hospital delirium?
Delirium prevention addresses several modifiable stresses together: orientation, sleep, mobility, hydration, nutrition, sensory support, pain, and medication burden. Glasses and hearing aids improve meaningful environmental input; daytime activity and reduced nighttime disruption support sleep–wake regulation. Medication review reduces avoidable sedating or anticholinergic exposure. These measures work as coordinated care rather than one isolated intervention. New symptoms still require evaluation because prevention does not eliminate delirium risk or justify overlooking an acute medical precipitant.
Apply it
An older inpatient has hearing loss, poor sleep, limited mobility, and little oral intake. Coordinate hearing support, orientation, assisted movement, fluids, and nighttime routines while reviewing medications instead of waiting for agitation before addressing these vulnerabilities.
Common pitfall: A sedative that makes the ward quieter does not necessarily improve delirium. Restricting movement and sensory input can worsen the very vulnerabilities that prevention should address.
Hartford Institute for Geriatric Nursing: Delirium Prevention and Management
41.How should a fall be connected to modifiable treatment and functional contributors?
Reconstruct the circumstances and timing of the fall, then examine plausible contributors rather than assigning a single cause from age alone. In a patient with diabetes, missed meals and hypoglycemia may combine with medication-related sedation, postural symptoms, weakness, or difficulty reaching the toilet. Review glucose patterns, actual medication use, standing blood pressure when indicated, and the functional task involved. An identified contributor should lead to a specific intervention and reassessment.
Apply it
A patient falls while walking to the bathroom after poor intake and a newly sedating medicine; glucose monitoring also shows overnight lows. Address hypoglycemia and the medication exposure, assess safe transfers and toilet access, and check for symptomatic postural changes.
Common pitfall: Finding one plausible contributor does not prove it was the only cause. Simply advising greater caution leaves medication, glucose, and task-related hazards unresolved.
ADA: Older Adults—Standards of Care in Diabetes, 2026 · CDC STEADI: Measuring Orthostatic Blood Pressure · NIDDK: Definition and Facts for Bladder Control Problems
42.What distinguishes functional incontinence from a bladder storage disorder?
Functional incontinence occurs when physical limitations, cognitive problems, or environmental barriers prevent timely toilet use despite no necessary primary bladder storage defect. The important clue is the pathway between recognizing the need and reaching or using the toilet. Mobility, clothing, lighting, assistance, and toilet access can be decisive. Treatment should address the identified barrier and toileting support. Coexisting urgency or other urinary disease remains possible and should be assessed rather than assumed absent.
Apply it
An older adult remains dry when assisted promptly but wets clothing while struggling with a distant bathroom and difficult fasteners. Improve toilet access, clothing, and assistance before assuming a bladder-relaxing medication will solve the problem.
Common pitfall: Calling every leakage episode overactive bladder can miss a practical access problem. Functional barriers and urinary pathology may coexist, so one finding does not exclude the other.
43.Which symptom patterns distinguish stress and urgency incontinence?
Stress incontinence produces leakage when physical pressure rises, such as with coughing, sneezing, lifting, or exercise. Urgency incontinence involves a sudden compelling urge followed by leakage before reaching the toilet. Some patients have both patterns, termed mixed incontinence. Ask about the event immediately preceding leakage rather than relying on the amount lost. Clarifying the predominant bothersome mechanism helps direct further assessment and management and prevents an unrelated treatment from being chosen solely because leakage is present.
Apply it
One patient leaks with coughing without warning urgency; another leaks while rushing after a sudden urge. Identify stress and urgency patterns respectively, and ask each patient about the other pattern before deciding whether mixed symptoms are present.
Common pitfall: Leak volume alone does not reliably distinguish mechanisms. A patient can have mixed incontinence, so finding one recognizable trigger should not end the symptom history.
44.When should overflow incontinence be suspected?
Overflow incontinence occurs when the bladder does not empty adequately and leakage follows overfilling. Clues include difficulty initiating urination, a weak stream, incomplete emptying, and frequent small leaks, although symptoms alone do not establish retention. Consider outlet obstruction, impaired bladder contraction, and medication contributors. Assessment of residual urine helps distinguish an emptying problem from a pure storage disorder. The management question is why emptying fails, rather than simply how to suppress leakage.
Apply it
An older man reports a weak stream, persistent fullness, and repeated small leaks. Assess bladder emptying and possible obstruction before prescribing treatment aimed at urgency, because unrecognized retention would change the appropriate management strategy substantially.
Common pitfall: Frequent leakage does not prove frequent effective emptying. Treating presumed urgency without checking a convincing retention history can worsen an underlying bladder emptying problem.
45.How do stage 1 and stage 2 pressure injuries differ from moisture-associated skin damage?
Stage 1 is intact skin with localized nonblanchable erythema; temperature, firmness, and sensation can help recognition, especially in darker skin. Stage 2 has partial-thickness loss with exposed viable pink or red moist dermis, sometimes a serum-filled blister, without adipose, granulation tissue, slough, or eschar. Establish pressure or shear as the mechanism. Incontinence-associated dermatitis, skin tears, adhesive injuries, burns, and abrasions should not be classified as stage 2 merely because they are superficial. Purple or maroon discoloration suggests assessment for deep tissue injury.
Apply it
An immobile patient has intact nonblanching sacral erythema and a separate shallow pressure-loaded lesion with exposed moist dermis: assess stage 1 and stage 2 respectively. Diffuse perineal erosion associated with urine and stool exposure instead suggests moisture-associated dermatitis.
Common pitfall: Surface depth alone does not establish pressure injury. Moisture damage and pressure injury can coexist, so evaluate each lesion’s mechanism and tissue findings and relieve the relevant exposure.
Geriatric Medicine Blueprint: Certification Examination (CERT) · NPIAP Pressure Injury Stages
46.Which findings indicate a deep tissue pressure injury?
Deep tissue pressure injury presents as persistent nonblanchable deep red, maroon, or purple discoloration, or epidermal separation revealing a dark wound bed or blood-filled blister. It results from intense or prolonged pressure and shear affecting deeper tissue. Pain and temperature changes may precede visible findings, and the injury can evolve rapidly. NPIAP cautions against using the label for unrelated vascular, traumatic, neuropathic, or dermatologic conditions; the pressure and shear context matters.
Apply it
An immobile patient develops a persistent maroon heel patch with a blood-filled blister after prolonged pressure exposure. Recognize possible deep tissue pressure injury and assess urgently rather than calling it stage 1 merely because much skin remains intact.
Common pitfall: Purple discoloration is not automatically a pressure injury. Establish the mechanism and consider mimics, while avoiding reassurance based only on an intact superficial skin layer.
47.How should frailty alter the balance of diabetes treatment?
Frailty and substantial functional impairment reduce tolerance for hypoglycemia, weight loss, dehydration, and complicated self-management. ADA recommends incorporating functional, cognitive, nutritional, and social assessment into treatment planning rather than allowing a glucose value to dominate. Preserve strength, daily function, comfort, and feasible care while preventing symptomatic extremes. A medication that helps a robust patient may create disproportionate burden in someone with limited reserve. Frailty should trigger individualization, not abandonment of beneficial care.
Apply it
A frail older adult has difficulty preparing meals, recurrent dizziness, and an intensive diabetes regimen. Reassess the target, medication burden, nutrition, and practical support together so that treatment improves daily safety rather than only a laboratory result.
Common pitfall: Frailty is not a reason to stop all treatment. It changes which outcomes matter most and increases the importance of avoiding burdens that exceed likely benefit.
48.Why does unintentional weight loss change nutrition advice in older adults?
ADA emphasizes adequate nutrition and protein intake in older adults, particularly when malnutrition, sarcopenia, or frailty threatens function. Restrictive diets can worsen poor intake and make hypoglycemia more likely when treatment assumes regular meals. Unintentional weight loss requires assessment of intake, illness, oral problems, mood, function, and medication effects. The immediate goal may be nutritional recovery and preserved muscle rather than weight reduction. Appropriate resistance and weight-bearing activity should accompany a feasible nutritional plan.
Apply it
An older adult with diabetes loses weight after adopting a very restrictive diet and skipping meals. Review the cause, relax unnecessary restrictions, support adequate intake, and reassess hypoglycemia-causing medication rather than congratulating the weight change without evaluation.
Common pitfall: Weight loss is not always a favorable metabolic outcome. Intentional obesity management and unexplained loss in a frail adult require different assessments and different treatment priorities.
Functional Assessment and Rehabilitation3%
49.How do instrumental activities reveal threats to independent living?
Instrumental activities of daily living assess complex tasks such as medication management, finances, shopping, transportation, food preparation, housekeeping, laundry, and telephone use. The Lawton scale helps identify support needs and compare function over time. Interpret performance against prior ability and opportunity: never having managed finances differs from losing that skill. Collateral history and concrete examples help separate cognitive, physical, sensory, and environmental causes. An IADL limitation signals a problem to investigate, not a diagnosis by itself.
Apply it
A patient still dresses and eats independently but has begun paying bills twice and mixing medication containers. Assess IADLs and their change from baseline, investigate causes, and arrange targeted support before basic self-care dependence develops.
Common pitfall: Independence in basic self-care does not prove safe independent living. Scores also require context because customary household roles can hide ability or make unfamiliar tasks appear impaired.
HIGN: The Lawton Instrumental Activities of Daily Living Scale · HIGN Try This: The Lawton Instrumental Activities of Daily Living Scale
50.How should rehabilitation potential be assessed after new disability?
Compare current task performance with prior function, identify the impairments preventing a meaningful goal, and assess what improves with treatment, practice, assistance, or environmental adaptation. After stroke, physical, occupational, and speech-language therapies address different motor, daily-task, communication, and swallowing needs. Recovery can continue over months or longer; a diagnosis alone does not specify the attainable outcome. NHLBI stroke recovery guidance describes interdisciplinary rehabilitation and adaptive devices.
Apply it
A previously independent stroke survivor now needs help transferring to the toilet. Set a concrete goal, assess transfers and communication, trial appropriate assistance and a nearby commode, and reassess observed performance as therapy proceeds.
Common pitfall: Neither age nor the presence of a disability establishes rehabilitation futility. Equipment provision alone does not prove improvement; confirm safe use and measurable progress toward the task.
Stroke - Recovery | NHLBI, NIH · HIGN: The Lawton Instrumental Activities of Daily Living Scale · NIDDK: Definition and Facts for Bladder Control Problems
Caring for Elderly Patients16%
51.What makes informed consent a meaningful clinical process?
AMA guidance describes informed consent as communication that enables an authorized, voluntary decision. Assess the patient’s ability to understand relevant information, disclose the diagnosis and purpose of proposed care, and discuss expected benefits, burdens, risks, and alternatives, including forgoing treatment. Invite questions and document the discussion and decision. Communication support may be needed before judging understanding. A signature records a decision but cannot substitute for disclosure, comprehension, or an opportunity to choose.
Apply it
An older adult signs a procedure form but cannot explain what the intervention is intended to accomplish. Pause to clarify the information in accessible language, check understanding, and resolve questions before treating the signature as sufficient consent.
Common pitfall: A signed form alone does not establish informed consent. Hearing loss or unfamiliar terminology can impair communication without demonstrating that the patient lacks decision-making capacity.
52.How should decision-making capacity and informed refusal be assessed?
Assess understanding of relevant information, appreciation of its personal consequences, reasoning about options, and communication of a choice. Capacity concerns the particular decision at the relevant time; a dementia diagnosis or disagreement does not settle it. Correct communication barriers and reversible contributors where possible. A patient with capacity may refuse recommended care after understanding consequences and alternatives. Document the assessment and voluntary decision and continue appropriate support.
Apply it
A patient with mild dementia explains a treatment’s purpose and alternatives, recognizes how refusal could affect her, and reasons consistently from longstanding priorities. Respect her informed refusal. Accurate repetition without recognition of personal consequences would require further assessment.
Common pitfall: A screening score does not replace decision-specific assessment. Neither an unwanted choice nor family disagreement proves incapacity, but factual recall alone does not prove intact appreciation.
AMA Code of Medical Ethics: Informed Consent · AMA Code of Medical Ethics: Patient Rights · AMA Code of Medical Ethics: Decisions for Adult Patients Who Lack Capacity
53.How should preventive care combine individualized cancer screening with vaccination?
For asymptomatic adults at average colorectal cancer risk, USPSTF recommends selective screening from ages 76 through 85 based on health, prior screening, and preferences; screening stops after 85. Symptoms such as bleeding or unexplained anemia instead require diagnostic assessment. Vaccination addresses a different preventive need: CDC recommends two recombinant zoster vaccine doses, generally two to six months apart, for adults at least 50, including those with previous shingles. See the [CDC shingles vaccination guidance](https://www.cdc.gov/shingles/vaccines/index.html).
Apply it
For a healthy 78-year-old never screened for colorectal cancer, discuss screening benefit and follow-up burden. Also check zoster vaccination even if shingles occurred years earlier. For a severely ill 84-year-old with adequate prior screening, colorectal screening may offer little benefit, but preventive decisions still require individual assessment.
Common pitfall: A decision to stop one screening service does not mean all prevention should stop. Prior shingles does not substitute for vaccination, and a screening age limit should not be used to dismiss possible cancer symptoms.
Geriatric Medicine Blueprint: Certification Examination (CERT) · Recommendation: Colorectal Cancer: Screening | United States Preventive Services Taskforce
54.How should surrogates distinguish substituted judgment from best interests?
When an adult lacks capacity, identify an appropriate surrogate under applicable law and policy and continue involving the patient as much as possible. Use substituted judgment when known statements, preferences, or values indicate what the patient would choose. If these cannot reasonably be inferred, use best interests, considering likely benefit, suffering, impairments, and experienced quality of life. Neither standard gives the surrogate unrestricted authority to substitute personal preferences or convenience.
Apply it
A patient’s repeated statements against prolonged machine dependence should inform substituted judgment. If no relevant preferences can be learned, help the surrogate compare likely benefits and burdens using best interests, while continuing efforts to understand the patient.
Common pitfall: Do not invent preferences to justify a favored outcome. General past comments require interpretation in the present circumstances, and surrogate authority depends on applicable law and policy.
AMA Code of Medical Ethics: Decisions for Adult Patients Who Lack Capacity
55.What establishes Medicare hospice eligibility and continued coverage?
Medicare Part A hospice requires care through a Medicare-certified hospice, physician certification of a prognosis of six months or less if the illness follows its normal course, and a signed election of the hospice benefit. Election accepts hospice care and waives separate Medicare payment for the terminal illness and related conditions outside hospice arrangements, subject to benefit exceptions. Coverage permits two 90-day periods followed by unlimited 60-day periods with recertification. The third period and subsequent recertifications require a documented qualifying face-to-face encounter.
Apply it
A patient with a certified qualifying prognosis elects hospice and remains alive after six months. Continued coverage is possible if recertification supports ongoing eligibility; survival beyond the original estimate does not automatically terminate the benefit.
Common pitfall: Palliative needs alone do not establish Medicare hospice eligibility. Hospice election does not waive Medicare coverage for all unrelated health problems, and six months is a prognostic criterion rather than a fixed coverage limit.
56.How should a complete medication history be built at a care transition?
AHRQ’s MATCH toolkit emphasizes establishing an accurate medication history and comparing it with transition orders. Include prescribed drugs, nonprescription products, supplements, actual use, dose, route, frequency, and relevant sources of information. A patient interview, caregiver report, medication containers, pharmacy information, and prior records may each reveal different discrepancies. Distinguish what was prescribed from what the patient actually takes. The resulting list must support clinical reconciliation and communication, rather than merely reproduce an earlier electronic list.
Apply it
At admission, an older adult’s electronic list conflicts with pill bottles and the caregiver’s account. Clarify actual use through multiple sources, document uncertainties, and compare the verified history with orders before assuming the electronic list is authoritative.
Common pitfall: Copying the prior list can preserve omissions and outdated therapies. Pharmacy dispensing information also does not prove that the patient is taking the medicine as directed.
AHRQ: Medications at Transitions and Clinical Handoffs Toolkit
57.How should medication discrepancies be resolved before discharge?
Reconciliation requires determining whether differences between prior therapy and current orders are intentional, clinically appropriate, and clearly communicated. AHRQ emphasizes resolving omissions, duplications, dose differences, and unclear changes with the responsible clinicians. The patient and next care team need one understandable plan explaining what to start, continue, change, and stop. A discrepancy is not automatically an error, but leaving its intent unexplained creates risk. Confirm understanding and assign responsibility for follow-up when uncertainty remains.
Apply it
A discharge list includes both a longstanding medicine and its inpatient replacement. Contact the prescribing team to establish intent, remove unintended duplication, and give the patient and receiving clinician the same corrected plan with an explanation of changes.
Common pitfall: Printing two conflicting lists transfers the reconciliation task to the patient. Deleting a discrepancy without checking intent can also reverse a deliberate and appropriate treatment change.
AHRQ: Medications at Transitions and Clinical Handoffs Toolkit
58.When can palliative care begin alongside disease-directed treatment?
NCI describes palliative care as care that improves quality of life by addressing physical symptoms and psychological, social, and spiritual concerns. It can begin at diagnosis and continue alongside treatment intended to control disease. It is not restricted to the last days of life. The practical indication is unmet need, such as pain, breathlessness, distress, or difficult decisions. Distinguish this concurrent supportive approach from hospice, which centers on comfort when curative treatment is no longer the goal.
Apply it
An older adult receiving active cancer treatment has persistent pain, anxiety, and family strain. Offer palliative care concurrently with oncology treatment rather than waiting until all disease-directed options have ended or death appears imminent to the family.
Common pitfall: Equating palliative care with stopping treatment delays useful symptom and decision support. Its role depends on needs and goals, not solely an estimate of remaining survival.
59.When can local cancer treatment be chosen specifically for pain relief?
Palliative treatment can target the cause of a symptom even when cure is not achievable. NCI describes radiation or chemotherapy to reduce a painful tumor and surgery to relieve painful pressure on nerves. For a localized painful tumor, consider whether directed treatment can reduce the local source of pain alongside an appropriate analgesic plan. Explain that the intended outcome is symptom relief and weigh treatment burden against the patient’s priorities, including alertness and time at home.
Apply it
An older adult with advanced cancer has pain concentrated at one tumor site and troublesome sedation from escalating analgesia. Assess targeted palliative radiotherapy with the oncology team while continuing symptom care, rather than treating further systemic analgesic escalation as the only available approach.
Common pitfall: A comfort-focused goal does not automatically exclude radiation, chemotherapy, or surgery. Their appropriateness depends on the expected symptom benefit, burdens, feasibility, and the patient’s goals.
60.Why should caregiver needs be assessed during serious illness?
Serious illness affects caregivers’ emotional health, practical responsibilities, relationships, and ability to sustain care. NCI includes caregiver support within palliative care, including help with coping, communication, and planning. Ask what tasks the caregiver performs, which are difficult, and what support is available. The patient’s plan may be clinically sound but unworkable if it assumes unlimited unpaid assistance. Assess caregiver needs while respecting patient confidentiality and involving the patient in decisions whenever possible.
Apply it
A spouse managing symptoms and appointments reports exhaustion and confusion about whom to call overnight. Assess caregiving demands, clarify contact pathways, and connect the family with palliative and practical support rather than simply adding more home instructions.
Common pitfall: A caregiver’s presence does not prove adequate capacity or willingness to provide every task. Ignoring exhaustion can undermine both patient care and the caregiver’s health.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Gerontology mapping: concepts 1–2 address interpretation of literature in aging; concept 3 addresses physiology, drug exposure, and alcohol sensitivity.
- Diseases mapping: concepts 4–5 and 7 address diabetes and cardiorenal treatment; 8 heart failure; 9–11 urinary infection; 12 and 14 CKD; 13 hypertension with CKD; 15 and 20 cerebrovascular disease; 16–18 AF and orthostatic hypotension; 19 and 23 osteoporosis; 21 COPD; 24–25 osteoarthritis; 26 iron-deficiency anemia and gastrointestinal evaluation; 27 giant cell arteritis; and 29–30 hearing loss.
- Psychiatry mapping: concepts 31 and 35 address depression; 32 harmful alcohol use; 33 suicide; and 34 bipolar disorder. Practise longitudinal assessment as well as immediate safety decisions.
- Cognitive mapping: concepts 6, 22, 28, and 36–38 address dementia treatment, cognitive evaluation, practical care, DLB, MCI, and Alzheimer-type dementia. Extend these selected topics using the official cognitive impairment and dementia subsections, which together account for 12.5% of the examination.
- Other syndromes mapping: concepts 39–40 address delirium; 41 falls; 42–44 incontinence; 45–46 pressure injuries, including stage 2 and moisture-associated mimics; 47 frailty; and 48 undernutrition and involuntary weight loss.
- Function mapping: concept 49 addresses disability assessment; concept 50 addresses rehabilitation potential, interdisciplinary care, adaptive equipment, and environmental modification.
- Caring mapping: concepts 51–52 and 54 address ethics and decision making; 53 individualized screening and vaccination; 56–57 transitions; and 55 and 58–60 palliative care, hospice, symptom treatment, and caregiver support.
- Give the largest study share to Diseases in the Elderly. Practise treatment selection, contraindications, diagnostic criteria, acute warning signs, and multimorbidity using the official subsection weights.
- Distinguish acute change from baseline impairment and connect symptoms with reversible contributors, medication burden, function, and environment.
- Practise absolute benefit calculations, quantitative AF risk assessment, and interpretation of uncertainty using complete clinical information.
- Use the complete CERT blueprint to extend review beyond this selective guide, including additional dermatologic, gastrointestinal, cardiovascular, preventive, and other organ-system topics.
A practical preparation plan
1. Map the complete certification outline
Create a study map from the August 2026 CERT blueprint. Allocate time approximately by the six published domain weights and their subsections, then increase attention to personal gaps without dropping smaller domains. Concept counts do not establish comprehensive coverage.
2. Build discriminating clinical comparisons
Compare delirium with chronic dementia, MCI with functionally impairing dementia, asymptomatic bacteriuria with symptomatic infection, sudden hearing loss with presbycusis, and storage incontinence with retention or access barriers. Record the finding that changes the decision.
3. Practise treatment benefit and treatment harm together
For each management problem, identify the intended outcome, likely time to benefit, contraindications, monitoring, functional demands, and patient priorities. Rehearse diabetes deintensification, heart-failure therapy, hypertension tolerance, anticoagulation thresholds, kidney monitoring, fracture prevention, and dementia care.
4. Complete and explain the question set
Answer the 20 questions independently. For each error, explain why the selected option fails and what specific finding supports the best option. Use the flashcards later to test the underlying principle without the vignette.
5. Integrate clinical data and competing explanations
Interpret ECGs, imaging, laboratory patterns, spirometry, and clinical illustrations alongside the history. State the decisive criterion, distinguish a threshold result from a confirmed diagnosis, and identify what additional finding would change management.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ABFM: Geriatric Medicine
- ABFM: Geriatric Medicine One-Day Exam
- 2026 Geriatric Medicine Certificate of Added Qualification One-Day Examination Information Booklet
- ABIM: Blueprints
- Geriatric Medicine Blueprint: Certification Examination (CERT)
- Geriatric Medicine MOC Blueprint, April 2026
- ABIM: Expanded Blueprints
- Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
- CDC STEADI: Measuring Orthostatic Blood Pressure
- ADA: Older Adults—Standards of Care in Diabetes, 2026
- IDSA 2019 Clinical Practice Guideline for Asymptomatic Bacteriuria
- BHOF September 2024 Submission and Supporting Osteoporosis Materials
- The clinician's guide to prevention and treatment of osteoporosis, 2022
- 2021 ACR/Vasculitis Foundation Guideline for Giant Cell Arteritis and Takayasu Arteritis
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
- 2019 ACR/Arthritis Foundation Guideline for Osteoarthritis of the Hand, Hip, and Knee
- NIDCD: Age-Related Hearing Loss (Presbycusis)
- NIDCD: Sudden Sensorineural Hearing Loss
- NIMH: Depression
- NIMH: Adult Outpatient Brief Suicide Safety Assessment Guide
- Hartford Institute for Geriatric Nursing: Delirium Prevention and Management
- NIA: Lewy Body Dementia—Causes, Symptoms, and Diagnosis
- NIDDK: Definition and Facts for Bladder Control Problems
- NPIAP Pressure Injury Stages
- HIGN: The Lawton Instrumental Activities of Daily Living Scale
- HIGN Try This: The Lawton Instrumental Activities of Daily Living Scale
- AMA Code of Medical Ethics: Patient Rights
- AMA Code of Medical Ethics: Informed Consent
- AMA Code of Medical Ethics: Decisions for Adult Patients Who Lack Capacity
- NCI: Palliative Care in Cancer
- AHRQ: Medications at Transitions and Clinical Handoffs Toolkit
- Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, 2017
- The clinician's guide to prevention and treatment of osteoporosis, 2022—mirrored primary publication
- NIH: Lewy Body Dementia—Information for Patients, Families, and Professionals, September 2013—mirrored booklet
- 2026-Examination-Information-Booklet-Geriatric-Medicine-v.1.0.pdf
- Hospice | CMS
- Hospice Care Coverage
- COPD - Diagnosis | NHLBI, NIH
- Anemia - Diagnosis | NHLBI, NIH
- PIIS0016508520348472-1.pdf
- Aging and Alcohol | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Bipolar Disorder - National Institute of Mental Health (NIMH)
- Stroke - Recovery | NHLBI, NIH
- the-diagnosis-of-mild-cognitive-impairment-due-to-alzheimer%27s.pdf
- Recommendation: Colorectal Cancer: Screening | United States Preventive Services Taskforce
- 2.1.2_1.pdf
- GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD - PMC
- Symptoms of Bipolar Disorder May Go Undiagnosed in Some Adults with Major Depression - National Institute of Mental Health (NIMH)
- the-diagnosis-of-dementia-due-to-alzheimer%27s-disease.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.